Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

May Alattar

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|March 24, 2012
Elevated amylase and lipase levels in patients using glucagonlike peptide-1 receptor agonists or dipeptidyl-peptidase-4 inhibitors in the outpatient settingHoward M Lando, May Alattar, Anuradha P Dua
Cureus|April 22, 2020
Is Testosterone Replacement Safe in Men with Cardiovascular Disease?Talha Ahmed, May Alattar, Kevin Pantalone, et al.
Diabetes Care|November 7, 2013
Exenatide treatment for 6 months improves insulin sensitivity in adults with type 1 diabetesGayatri Sarkar, May Alattar, Rebecca J Brown, et al.
Diabetes Care|September 25, 2014
Response to comment on Sarkar et al. Exenatide treatment for 6 months improves insulin sensitivity in adults with type 1 diabetes. Diabetes care 2014;37:666-670Gayatri Sarkar, May Alattar, Rebecca J Brown, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|March 24, 2012
Elevated amylase and lipase levels in patients using glucagonlike peptide-1 receptor agonists or dipeptidyl-peptidase-4 inhibitors in the outpatient settingHoward M Lando, May Alattar, Anuradha P Dua
Cureus|April 22, 2020
Is Testosterone Replacement Safe in Men with Cardiovascular Disease?Talha Ahmed, May Alattar, Kevin Pantalone, et al.
Diabetes Care|November 7, 2013
Exenatide treatment for 6 months improves insulin sensitivity in adults with type 1 diabetesGayatri Sarkar, May Alattar, Rebecca J Brown, et al.
Diabetes Care|September 25, 2014
Response to comment on Sarkar et al. Exenatide treatment for 6 months improves insulin sensitivity in adults with type 1 diabetes. Diabetes care 2014;37:666-670Gayatri Sarkar, May Alattar, Rebecca J Brown, et al.
Pageof 1